MYDA Advisors’s DarioHealth DRIO Stock Holding History

MYDA Advisors’s Portfolio DRIO Stock Details DRIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-75	Closed	-$14K	–	126
2019 Q2	$14K	Buy	+75	New	+$19.5K	﹤0.01%	93

Other funds holding DRIO

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

MIH

Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

MIM

Marco Investment Management Atlanta, Georgia $1.33B AUM 32.43% 1-Year Est. Return

MYDA Advisors's DRIO Position: Q3 2019 in Review

MYDA Advisors sold out of DarioHealth (DRIO) in Q3 2019, closing a stake of 75 shares — an estimated $14K sold.

MYDA Advisors first reported a position in DRIO in Q2 2019 and held it in 1 quarter. The position peaked at $14K in Q2 2019. 19 funds tracked by Wall St. Rank hold DRIO as of Q3 2019.

MYDA Advisors reported no remaining DarioHealth position as of Q3 2019 after selling out during the quarter.
MYDA Advisors sold 75 DarioHealth shares in Q3 2019, an estimated $14K.
MYDA Advisors first reported a position in DarioHealth in Q2 2019 and held it in 1 quarter.
MYDA Advisors's DarioHealth position peaked at $14K in Q2 2019.
19 funds tracked by Wall St. Rank held DarioHealth as of Q3 2019.

Based on MYDA Advisors's 13F filing for Q3 2019, filed 13 Nov 2019.